NCT02675894 is a NA clinical trial of cooled-wet electrode in HCC, sponsored by Seoul National University Hospital.

Who is sponsoring NCT02675894?

NCT02675894 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT02675894?

Interventions in NCT02675894: cooled-wet electrode, separable clustered electrode.

What condition does NCT02675894 study?

NCT02675894 studies HCC, Metastasis.

Is NCT02675894 still recruiting?

NCT02675894 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT02675894

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiofrequency Ablation Using Cooled-Wet Electrode

Completed NA Last updated 18 March 2021

What this trial tests

NA trial testing cooled-wet electrode in HCC in 77 participants. Completed in 24 April 2018.

Timeline

14 April 2014

Primary endpoint
19 January 2017

24 April 2018

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	77
Start date	14 April 2014
Primary completion	19 January 2017
Estimated completion	24 April 2018
Sites	1 location across South Korea

Drugs / interventions tested

cooled-wet electrode
separable clustered electrode

Conditions studied

HCC — all drugs for HCC →
Metastasis — all drugs for Metastasis →

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 75, any sex, with HCC or Metastasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine safety, ablative zone, technical success rate and early safety data of recently introduced cool-wet electrode in eligible patients who are indicative for radiofrequency ablation (RFA) for liver tumors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial.
Chang W, Lee JM, Lee DH, Yoon JH, et al · · 2018 · cited 14× · PMID 29420589 · DOI 10.1371/journal.pone.0192173

Verify or expand the search:

Other recruiting trials for HCC

Currently open trials in the same condition.

NCT07145801 — Y-90 Treatment Response Using Transarterial Radioembolization · Phase 2 · recruiting
NCT07300488 — Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma · Phase 2, PHASE3 · active not recruiting
NCT07334483 — A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC · Phase 2 · recruiting
NCT07099274 — Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy f · Phase 2 · recruiting
NCT06717919 — HOPE Against Cancer Recurrence in HCC · Phase 4 · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02675894 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02675894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing